ELEVATED LP(A)
Clinical trials for ELEVATED LP(A) explained in plain language.
Never miss a new study
Get alerted when new ELEVATED LP(A) trials appear
Sign up with your email to follow new studies for ELEVATED LP(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill tame a hidden heart risk?
Disease control OngoingThis early-stage trial tests an experimental oral drug called SAL0137 in healthy adults, some with elevated Lp(a), a genetic risk factor for heart disease. The study aims to check the drug's safety, how the body processes it, and its effect on Lp(a) levels. Participants receive e…
Matched conditions: ELEVATED LP(A)
Phase: PHASE1 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New shot aims to slash heart attacks in 17,300 with hidden cholesterol risk
Disease control OngoingThis large Phase 3 study tests an injectable drug called lepodisiran in about 17,300 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease and stroke. Participants either already have heart disease or are at high risk for a first heart event. The goal…
Matched conditions: ELEVATED LP(A)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC